Health care regulation, the Food and Drug Administration (FDA), and access to medicine : Our experience with dupilumab for children - 17/02/20
Doi : 10.1016/j.jaad.2020.01.019
Chang Ye Wang, MD a, ⁎ 
, Rui Rui Chloe Zheng, JD b, Zachary A. Doerrer, BSc c, Anastasia O. Kurta, DO a, Jacob J. Shelley, SJD b, d, Elaine C. Siegfried, MD a
, Rui Rui Chloe Zheng, JD b, Zachary A. Doerrer, BSc c, Anastasia O. Kurta, DO a, Jacob J. Shelley, SJD b, d, Elaine C. Siegfried, MD a a Department of Dermatology, Saint Louis University, St Louis, Missouri
b Faculty of Law, University of Western Ontario, London, Ontario, Canada
c School of Medicine, Saint Louis University, St Louis, Missouri
d School of Health Studies, University of Western Ontario, London, Ontario, Canada
∗Correspondence to: Chang Ye Wang, MD, 1755 S Grand Blvd, St Louis, MO 63104.1755 S Grand BlvdSt LouisMO63104
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Monday 17 February 2020
Abbreviations used : FDA
Le texte complet de cet article est disponible en PDF.
| Authors Wang and Zheng contributed equally to this work. |
|
| Funding sources: None. |
|
| Conflicts of interest: Dr Siegfried, possibly related: principal investigator clinical trial, consulting fees, and honorarium for Regeneron; consulting fees and honorarium for Sanofi Genzyme; consulting fees for UCB and AbbVie. Unrelated: consulting fees and honorarium for Verrica; consulting fees and Data Safety Monitoring Committees for LEO Pharma and Novan; consulting fees for Pfizer and Pierre Fabre; principal investigator, clinical trial for Janssen; and principal investigator for Lilly. Authors Wang, Zheng, Doerrer, Kurta, and Shelley have no conflicts of interest to declare. |
|
| IRB approval status: The primary data used in this article are obtained from studies approved by the SLU IRB. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?